Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OSBP | P22059 | 13/20 | 0.73 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.68 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Schweinfurthin E SCHEMBL24867154 | 0.97 | OSBP (0.77) | OSBPOSBP2CYP19A1PTGS2ALOX5 | |
| SCHEMBL13076642 | 0.93 | OSBP (0.71) | OSBPOSBP2CYP19A1PTGS2ALOX5 | |
| SCHEMBL30935456 | 0.91 | OSBP (0.70) | OSBPOSBP2CYP19A1PTGS2ALOX5 | |
| SCHEMBL24867422 | 0.91 | OSBP (0.70) | OSBPOSBP2CYP19A1PTGS2ALOX5 | |
| SCHEMBL20003838 | 0.91 | OSBP (0.72) | OSBPOSBP2CYP19A1PTGS2 | |
| Schweinfurthin B SCHEMBL847454 | 0.90 | OSBP (0.85) | OSBPOSBP2 | |
| Schweinfurthin B SCHEMBL12042782 | 0.90 | OSBP (0.85) | OSBPOSBP2 | |
| Vedelianin SCHEMBL30978359 | 0.88 | OSBP (0.84) | OSBPOSBP2CYP19A1 | |
| Vedelianin SCHEMBL30169535 | 0.88 | OSBP (0.84) | OSBPOSBP2CYP19A1 | |
| SCHEMBL30935444 | 0.87 | OSBP (0.58) | OSBPOSBP2CYP19A1PTGS2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432466-B1 | SCHWEINFURTHINS AND USES THEREOF | US HEALTH (US) | 2018-03-28 | — | — | EP | disclosed |
| US-20120095089-A1 | SCHWEINFURTHINS AND USES THEREOF | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2012-04-19 | — | — | US | disclosed |
| US-20120095089-A1 | SCHWEINFURTHINS AND USES THEREOF | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2012-04-19 | — | — | US | disclosed |
| WO-2010127235-A1 | SCHWEINFURTHINS AND USES THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2010-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095089-A1 | SCHWEINFURTHINS AND USES THEREOF | VHL, WFS1, UPF1 | OSBP 4011/4885OSBP2 3204/4885CYP19A1 1016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.